Brookline Capital Management boosted their FY2024 earnings per share estimates for CRISPR Therapeutics in a research note issued on Monday, January 6th. Brookline Capital Management analyst L. Cann ...
Nordea Investment Management AB grew its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.4% in the ...
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...
This Fool has his eye on an innovative growth stock that has plunged by 80% since early 2021. But what is so special about it ...
We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look ...
Zacks.com on MSN3d
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to NoteCRISPR Therapeutics AG (CRSP) closed the most recent trading day at $41.92, moving -1.2% from the previous trading session.
We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...
Check the time stamp on this data. Updated AI-Generated Signals for Crispr Therapeutics Ag (CRSP) available here: CRSP.
Read about how Crispr's robust pipeline for cardiovascular diseases holds blockbuster potential, with top-line results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback